Etiome, a company redefining how we detect and preempt disease progression.
Etiome has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Etiome's investors include Flagship Pioneering.
Etiome is headquartered in Cambridge, United States.
Etiome, a company redefining how we detect and preempt disease progression.
Etiome is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Etiome — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/etiome. Accessed July 21, 2026.
VCBacked. (2025). Etiome — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/etiome
{{cite web |title=Etiome — Funding & Investors |url=https://www.vcbacked.co/company/etiome |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated